Uso del tamoxifeno en las alteraciones fibroquísticas de la mama
Abstract
Se realizó un estudio longitudinal, prospectivo observacional en 30 pacientes que acudieron a la consulta externa del servicio de cirugía general del Hospital Militar Clínico Quirúrgico Docente "Octavio de la Concepción y de la Pedraja", en el primer semestre del año 2000 con el diagnóstico clínico de alteración fibroquística de la mama; a las cuales se les aplicó tratamiento con Tamoxifeno 10 mg / por vía oral diario, durante tres meses. Todas las pacientes que conformaron la muestra cumplían dos premisas fundamentales: a) haber procreado, b) rango de edad entre 25-35 años. La efectividad del tratamiento a los tres meses fue excelente, no se observaron efectos adversos.Downloads
Downloads
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/